≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other specified disorders of external ear

DOID EFO Endpoint Browser PheWeb

H8_EXTDISNAS

external ear disease: A disease involving the external ear. [database_cross_reference: MONDO:DesignPattern]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H61.8, H61.9
  • Hospital discharge: ICD-9 — 380[8-9]
  • Cause of death: ICD-10 — H61.8, H61.9
  • Cause of death: ICD-9 — 380[8-9]

2 out of 7 registries used, show all original rules.

1304

4. Check minimum number of events

None

1304

5. Include endpoints

None

1304

6. Filter based on genotype QC (FinnGen only)

1304

Control definitions (FinnGen only)

Control exclude
H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8281 2364 5883
Only index persons 7659 2206 5453
Unadjusted period prevalence (%)
Whole population 0.14 0.07 0.16
Only index persons 0.17 0.08 0.21
Median age at first event (years)
Whole population 54.74 53.01 55.43
Only index persons 55.12 53.64 55.72

-FinnGen-

Key figures

All Female Male
Number of individuals 1304 331 973
Unadjusted period prevalence (%) 0.35 0.11 0.43
Median age at first event (years) 59.23 57.41 59.85

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1150
Matched controls
11501
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H61.8
ICD-10 Finland
Other specified disorders of external ear
4854.9
323.0
988
15
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
744.6
196.2
188
*
DBB00
NOMESCO Finland
Excision of lesion of external auditory canal
2025.7
176.7
167
*
H61.9
ICD-10 Finland
Disorder of external ear, unspecified
161.3
98.9
103
7
3808A
ICD-9 Finland
Disorders of external ear, Other disorders of external ear[EXOSTOSIS MEATUS ACUSTICI EXTERNI]
+∞
87.6
83
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
8.7
80.8
185
247
H61.3
ICD-10 Finland
Acquired stenosis of external ear canal
799.4
77.2
75
*
UDC00
NOMESCO Finland
Ear microscopy
6.3
76.8
224
425
4112
FHL
Removal of ear canal tumor (eg exostosis)
697.2
67.7
66
*
DFF00
NOMESCO Finland
Pure tone audiometry
5.1
65.7
230
536
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.1
65.1
294
884
H60.3
ICD-10 Finland
Other infective otitis externa
25.3
61.6
87
37
H61.2
ICD-10 Finland
Impacted cerumen
7.2
55.7
143
223
H60.8
ICD-10 Finland
Other otitis externa
19.0
55.0
85
48
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.9
40.0
300
1266
H29
ICPC
Ear symptom/complaint other
3.2
27.9
162
565
DC1AD
NOMESCO Finland
Temporalbone CT
12.2
26.4
48
41
H60.4
ICD-10 Finland
Cholesteatoma of external ear
95.6
25.7
28
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
3.4
23.8
124
398
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
4.3
23.1
89
221
H60
ICD-10 Finland
Otitis externa
4.8
22.9
79
175
H01
ICPC
Ear pain/earache
3.1
22.4
130
449
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.1
21.9
291
1583
DBW99
NOMESCO Finland
Other operation on external auditory canal
+∞
20.9
20
*
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
11.2
20.8
39
36
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
5.5
20.3
61
116
H13
ICPC
Plugged feeling ear
2.1
20.2
252
1327
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
7.7
19.8
46
62
H81
ICPC
Excessive ear wax
2.2
19.6
233
1203
S02CA02
ATC
flumetasone and antiinfectives; otic
3.6
19.2
90
266
H71
ICD-10 Finland
Cholesteatoma of middle ear
10.6
18.7
36
35
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
18.4
339
2073
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.7
18.2
82
235
M01AH05
ATC
etoricoxib; oral
1.7
18.1
636
4788
N02BE01
ATC
paracetamol; systemic, rectal
2.0
17.4
964
8331
A98
ICPC
Health maint/preventive medicine
2.6
17.2
1082
9853
H02
ICPC
Hearing complaint
2.3
17.1
174
832
ZXA05
NOMESCO Finland
Left side
1.9
16.9
308
1868
J01DA01
ATC
[U] cefalexin; systemic
1.7
16.7
673
5215
H65.3
ICD-10 Finland
Chronic mucoid otitis media
6.4
16.0
42
68
ZXA00
NOMESCO Finland
Right side
1.8
15.8
329
2079
H70
ICPC
Otitis externa
5.7
15.7
45
82
DAB00
NOMESCO Finland
Excision of lesion of auricle
7.8
15.4
35
46
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
15.4
161
778
J01DB01
ATC
cefalexin; oral
1.8
15.4
907
7760
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
15.3
539
3980
DFF15
NOMESCO Finland
Speech audiometry
3.5
15.3
73
220
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
4.9
14.3
46
96
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
14.2
417
2910
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
13.7
505
3738
DAX08
NOMESCO Finland
Fitting of hearing aid
3.2
13.6
72
235
S18
ICPC
Laceration/cut
1.6
13.4
495
3657
M01AE01
ATC
ibuprofen; systemic, rectal
1.8
13.4
971
8595
H60.1
ICD-10 Finland
Cellulitis of external ear
11.1
13.0
24
22
H61.0
ICD-10 Finland
Perichondritis of external ear
50.6
12.9
15
*
J01CA04
ATC
amoxicillin; systemic
1.7
12.8
854
7302
DCD00
NOMESCO Finland
Myringoplasty
11.7
12.8
23
20
4111
FHL
Ear canal extension
131.3
12.5
13
*
E0000UV
ATC
NA
1.6
12.4
399
2824
H66.9
ICD-10 Finland
Otitis media, unspecified
3.2
12.3
65
212
R01AD08
ATC
fluticasone; nasal
1.7
12.1
279
1798
WX110
NOMESCO Finland
Local anesthesy
1.6
11.9
724
5983
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
11.8
519
3966
Z97.4
ICD-10 Finland
Presence of external hearing-aid
2.9
11.7
73
266
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
11.6
141
723
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.5
11.6
54
161
H65.0
ICD-10 Finland
Acute serous otitis media
8.7
11.5
24
28
R01AD12
ATC
fluticasone furoate; nasal
1.7
11.4
269
1740
L08
ICPC
Shoulder symptom/complaint
1.8
11.3
217
1318
Z01.2
ICD-10 Finland
Dental examination
1.6
11.2
394
2840
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
11.2
410
2984
H60.0
ICD-10 Finland
Abscess of external ear
20.2
11.1
16
8
TDA90
NOMESCO Finland
Removal wax from ear
5.5
11.1
32
60
D82
ICPC
Teeth/gum disease
1.6
11.0
332
2300
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
10.9
210
1278
K02.1
ICD-10 Finland
Caries of dentine
1.5
10.8
570
4508
M01AE02
ATC
naproxen; oral, rectal
1.5
10.7
573
4548
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
60.5
10.6
12
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
10.6
399
2916
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
11.3
10.6
19
17
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
10.6
284
1902
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
7.4
10.5
24
33
D01BA02
ATC
terbinafine; oral; topical
1.6
10.4
299
2039
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
3.0
10.2
59
206
SPAT1043
SPAT
Audiometry
2.0
10.2
131
690
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
10.0
196
1197
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.2
10.0
51
164
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
9.9
440
3328
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
4.6
9.9
33
73
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
9.9
211
1321
H04
ICPC
Ear discharge
3.3
9.9
49
154
WX002
NOMESCO Finland
Sedation and analgesia
1.7
9.8
224
1431
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.9
9.8
150
840
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
9.7
419
3143
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.7
9.7
229
1475
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
5.6
9.7
27
49
H93.1
ICD-10 Finland
Tinnitus
2.4
9.6
81
354
M01AB05
ATC
diclofenac; systemic, rectal
1.5
9.3
698
5871
ZXE00
NOMESCO Finland
One hour or less
1.5
9.3
406
3049
J01FA10
ATC
azithromycin; systemic
1.5
9.3
526
4171
N02AX02
ATC
tramadol; systemic, rectal
1.5
9.2
467
3619
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
9.0
254
1716
R01AD09
ATC
mometasone; nasal
1.5
9.0
407
3075
L17
ICPC
Foot/toe symptom/complaint
1.6
9.0
252
1701
H65.2
ICD-10 Finland
Chronic serous otitis media
5.5
8.9
25
46
H92.0
ICD-10 Finland
Otalgia
3.0
8.8
48
162
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.3
8.8
79
355
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
8.8
618
5103
J01AA02
ATC
doxycycline; systemic
1.5
8.6
818
7164
G47.3
ICD-10 Finland
Sleep apnoea
1.6
8.5
257
1762
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
8.3
300
2150
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
4.5
8.3
28
64
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
8.2
180
1131
J01MA02
ATC
ciprofloxacin; systemic
1.5
8.1
434
3378
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
11.8
8.1
14
12
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
8.1
554
4523
J02AC01
ATC
fluconazole; systemic
1.5
8.0
288
2055
R06AX27
ATC
desloratadine; oral
1.6
7.9
217
1452
M79.6
ICD-10 Finland
Pain in limb
1.5
7.8
339
2522
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
7.8
222
1495
L57.0
ICD-10 Finland
Actinic keratosis
1.9
7.8
118
656
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
3.9
7.8
30
78
DGW00
NOMESCO Finland
Dilatation of eustachian tube
45.3
7.7
9
*
J05AB01
ATC
aciclovir; systemic
1.6
7.5
193
1265
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
3.2
7.5
38
123
J01FF01
ATC
clindamycin; systemic
1.5
7.5
283
2039
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
7.5
258
1823
A02BC02
ATC
pantoprazole; systemic
1.4
7.4
682
5842
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.0
7.3
95
500
AA1AD
NOMESCO Finland
CT of head and brain
1.5
7.3
260
1846
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
7.3
264
1882
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
9.4
7.3
14
15
M01AC06
ATC
meloxicam; systemic, rectal
1.5
7.2
350
2656
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.9
7.2
108
604
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
7.2
222
1529
H74.1
ICD-10 Finland
Adhesive middle ear disease
30.2
7.2
9
*
S29
ICPC
Skin symptom/complaint other
1.6
7.1
173
1119
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
7.0
245
1729
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
7.0
687
5919
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
7.0
364
2797
SPAT1312
SPAT
General health counselling
1.5
7.0
314
2344
D07AC01
ATC
betamethasone; topical
1.4
6.9
346
2637
WX320
NOMESCO Finland
Spinalanesthesy
1.5
6.9
242
1714
M54.5
ICD-10 Finland
Low back pain
1.5
6.9
306
2280
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.8
6.8
119
699
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
6.7
6.8
16
24
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
6.8
104
583
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
6.8
263
1906
SPAT1153
SPAT
Removal of sutures
1.4
6.7
352
2704
H02AB06
ATC
prednisolone; systemic
1.4
6.7
479
3892
M03BX02
ATC
tizanidine; oral
1.4
6.7
595
5023
J34.2
ICD-10 Finland
Deviated nasal septum
2.1
6.7
69
332
R74
ICPC
Upper respiratory infection acute
1.5
6.7
218
1520
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
6.7
156
999
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.6
321
2430
R05
ICD-10 Finland
Cough
1.6
6.6
182
1218
A02BC05
ATC
esomeprazole; systemic
1.4
6.5
396
3127
X58
ICD-10 Finland
Exposure to other specified factors
1.7
6.5
142
892
N03AX16
ATC
pregabalin; oral
1.5
6.5
236
1681
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
6.4
233
1657
R5140
NOMESCO Finland
Monitoring the use of the aid
1.7
6.4
129
792
DBD10
NOMESCO Finland
Reconstruction of external auditory canal
70.2
6.4
7
*
DBB02
NOMESCO Finland
Excision of a neoplasm from external auditory canal
70.2
6.4
7
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
6.4
337
2587
R06AX13
ATC
loratadine; oral
1.7
6.4
125
760
M02AA07
ATC
piroxicam; topical
1.4
6.4
351
2718
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.5
6.3
221
1560
UJF32
NOMESCO Finland
Coloscopy
1.5
6.3
268
1970
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
6.3
287
2142
TDA10
NOMESCO Finland
Needle biopsy of auricle or external auditory canal
11.1
6.3
11
10
M01AX05
ATC
glucosamine; oral
1.6
6.3
186
1263
38798
ICD-8 Finland
Other disease of ear and mastoid process, Alii definiti
+∞
6.3
6
*
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
2.0
6.2
75
387
M25.5
ICD-10 Finland
Pain in joint
1.5
6.1
245
1779
R06.0
ICD-10 Finland
Dyspnoea
1.5
6.1
243
1764
ZXD20
NOMESCO Finland
Day surgery
1.7
6.1
122
747
R03AC02
ATC
salbutamol; inhalant
1.4
6.0
487
4022
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.0
534
4475

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
263
1363
2.16
25.09
5.0
4.7
%
32.5
31.8
0.39
175
931
(3013512) EKG study
499
3336
1.80
22.10
4.8
4.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
246
1323
2.06
20.98
1.9
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
747
5816
1.67
17.62
2.7
2.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1238
11292
2.90
17.10
12.3
10.9
u/l
27.4
27.7
0.17
1188
10896
(3010813) Leukocytes [#/volume] in Blood
1267
11726
3.84
16.66
27.0
23.2
e9/l
6.8
6.8
0.44
1231
11385
(3007461) Platelets [#/volume] in Blood
1266
11720
3.75
16.45
26.9
23.2
e9/l
235.3
239.0
1.31
1235
11416
(3024731) MCV [Entitic volume]
1266
11722
3.75
16.41
26.8
23.1
fl
91.5
91.4
0.16
1245
11544
(3035941) MCH [Entitic mass]
1266
11723
3.74
16.38
26.8
23.1
pg
30.6
30.5
0.42
1245
11543
(3026361) Erythrocytes [#/volume] in Blood
1266
11724
3.74
16.36
26.9
23.2
e12/l
4.5
4.5
0.50
1231
11381
(3000963) Hemoglobin [Mass/volume] in Blood
1266
11727
3.73
16.29
27.1
23.3
g/l
136.8
137.0
0.23
1246
11547
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1189
10757
2.19
14.83
5.5
5.2
mmol/l
2.6
2.6
0.02
1060
9880
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1130
10058
1.93
14.49
17.6
14.8
ml/min/173m2
77.9
78.6
0.59
993
8386
(3019550) Sodium [Moles/volume] in Serum or Plasma
1213
11082
2.36
14.44
21.3
18.9
mmol/l
139.8
139.7
0.52
1186
10822
(40761511) CBC panel - Blood by Automated count
1204
10983
2.25
14.10
17.9
15.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1159
10428
2.00
14.04
5.2
4.8
mmol/l
6.1
6.1
0.02
1028
9485
(40768804) Tissue Pathology biopsy report
548
4114
1.57
13.76
2.5
2.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1122
10005
1.87
13.72
6.7
6.2
mmol/mol
40.6
40.5
0.05
996
9250
(3013707) Erythrocyte sedimentation rate by Westergren method
925
7832
1.62
13.69
4.2
4.0
mm/h
12.9
12.6
0.22
829
7223
(3023103) Potassium [Moles/volume] in Serum or Plasma
1213
11119
2.30
13.68
21.5
19.0
mmol/l
4.0
4.0
0.34
1182
10848
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1169
10580
2.01
13.45
18.5
16.0
mg/l
25.5
26.9
0.66
966
8494
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1130
10120
1.87
13.33
4.5
4.2
mmol/l
1.3
1.3
0.18
1012
9231
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1164
10527
1.98
13.30
5.0
4.6
mmol/l
4.5
4.5
0.19
1047
9738
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
972
8368
1.63
13.06
8.8
7.9
u/l
77.3
79.8
1.22
914
7894
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1157
10456
1.95
13.05
5.1
4.6
mmol/l
1.4
1.4
1.18
1037
9598
(3044640) Blood type and Crossmatch panel - Blood
476
3499
1.57
12.89
2.2
2.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
804
6648
1.55
12.63
4.8
5.3
mmol/l
6.8
6.8
0.59
759
6269
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
385
2720
1.59
12.25
2.3
2.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
714
5777
1.52
12.22
6.8
6.7
umol/l
11.7
12.5
1.29
668
5498
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
573
4427
1.53
12.19
4.2
3.9
ng/l
36.0
67.2
1.73
430
3302
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1223
11330
2.28
12.05
21.0
18.8
umol/l
85.3
84.3
0.40
1223
11325
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1057
9369
1.68
11.85
4.9
4.2
mu/l
2.2
2.0
0.56
915
8485
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
588
4587
1.51
11.84
2.1
2.0
pmol/l
92.4
92.5
0.01
297
2542
(3019225) pH of Specimen
183
1078
1.81
11.47
4.3
4.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
490
3703
1.52
11.34
6.1
5.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
819
6909
1.50
10.85
3.7
3.3
u/l
49.1
55.9
1.84
741
6438
(3018010) Neutrophils/100 leukocytes in Blood
632
5073
1.48
10.67
5.7
5.9
%
58.2
58.0
0.14
578
4774
(3002030) Lymphocytes/100 leukocytes in Blood
639
5152
1.47
10.48
6.1
6.1
%
26.6
26.7
0.05
581
4819
(3019069) Monocytes/100 leukocytes in Blood
628
5048
1.47
10.45
6.2
6.3
%
8.9
9.0
0.31
573
4742
(3006504) Eosinophils/100 leukocytes in Blood
625
5029
1.47
10.29
5.9
6.0
%
2.9
2.9
0.17
572
4701
(3022217) INR in Platelet poor plasma by Coagulation assay
244
1602
1.64
10.28
30.1
26.9
inr
1.5
1.4
0.35
31
225
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
102
515
2.06
10.10
4.0
4.2
mmol/l
24.8
24.8
0.08
90
489
(3037467) Urinalysis macro (dipstick) panel - Urine
857
7351
1.48
10.03
5.0
4.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
191
1183
1.72
10.02
2.4
2.2
nmol/l
12.5
13.0
0.32
158
1046
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
139
790
1.85
9.75
3.7
3.8
mmol/l
1.4
1.8
0.58
105
592
(3022096) Basophils/100 leukocytes in Blood
605
4894
1.44
9.38
6.1
6.0
%
0.6
0.7
0.52
552
4587
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
448
3438
1.46
9.13
2.2
2.2
u/l
218.7
268.7
0.58
411
3230
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
457
3534
1.45
8.90
2.9
3.2
ng/l
1660.2
1572.3
0.15
376
3075
(3031040) Bacteria [#/volume] in Urine by Automated count
813
6981
1.44
8.87
5.2
4.3
e6/l
1379.3
1298.1
—
6
120
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
143
844
1.78
8.85
3.8
3.8
kpa
5.1
5.1
0.08
127
784
(3009343) pH of Capillary blood
141
832
1.78
8.74
3.8
3.8
ph
7.4
7.4
0.83
16
102
(3013115) Eosinophils [#/volume] in Blood
668
5551
1.42
8.67
6.0
5.9
e9/l
0.2
0.2
0.52
585
4878
(3042936) Bacteria identified in Isolate by Culture
248
1701
1.57
8.60
2.0
2.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
647
5356
1.41
8.53
5.7
5.7
e9/l
0.6
0.6
0.01
555
4611
(3006315) Basophils [#/volume] in Blood
649
5377
1.41
8.50
5.7
5.7
e9/l
0.0
0.0
0.14
559
4643
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
624
5157
1.40
8.18
4.0
4.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
655
5465
1.40
8.08
6.9
7.6
mmol/l
1.2
1.2
1.47
541
4628
(3009542) Hematocrit [Volume Fraction] of Blood
1043
9459
1.51
8.07
18.0
17.0
%
40.3
40.1
0.37
693
6464
(3019198) Lymphocytes [#/volume] in Blood
656
5490
1.39
7.87
5.7
5.8
e9/l
1.9
1.9
0.29
579
4837
(3013650) Neutrophils [#/volume] in Blood by Automated count
729
6213
1.39
7.82
8.9
9.1
e9/l
4.3
4.3
0.15
632
5439
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
438
3436
1.41
7.62
2.6
2.6
u/l
56.4
57.7
0.30
395
3194
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
852
7472
1.40
7.61
4.0
3.5
pmol/l
14.7
14.9
0.91
734
6728
(3032080) INR in Blood by Coagulation assay
596
4927
1.39
7.61
10.3
10.5
inr
1.3
1.3
0.07
165
1368
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
603
5009
1.38
7.41
6.4
6.7
mmol/l
1.2
1.2
1.09
534
4548
(3000494) Fungus identified in Specimen by Culture
195
1320
1.56
7.09
1.6
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
442
3520
1.39
6.89
3.5
3.5
mmol/l
2.4
2.3
0.85
352
3079
(3022145) Colonoscopy Study observation
178
1188
1.58
6.88
1.3
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
105
612
1.78
6.80
3.8
3.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
304
2275
1.44
6.75
1.6
1.7
mg/l
1.1
1.4
0.83
236
1789
(3002256) Pathology report gross observation
203
1404
1.53
6.69
1.4
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
30
106
2.87
6.55
1.0
1.1
u/ml
2.7
1.0
0.60
15
51
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
203
1418
1.51
6.37
4.9
4.1
u/l
231.7
244.3
1.24
193
1342
(3003888) Timothy IgE Ab [Units/volume] in Serum
30
109
2.79
6.24
1.0
1.0
u/ml
4.7
7.9
0.46
16
58
(40768443) Skin Pathology biopsy report
82
456
1.85
6.20
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
20
58
3.49
6.02
3.9
2.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
341
2666
1.38
5.78
6.8
6.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
725
6346
1.32
5.68
6.1
5.1
ug/l
3.0
3.1
0.09
639
5710
(3030467) Casts [#/volume] in Urine by Automated count
401
3228
1.35
5.62
3.7
3.2
e6/l
0.4
0.5
0.55
315
2483
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
480
3984
1.32
5.42
2.3
2.2
nmol/l
76.9
76.1
0.27
410
3546
(3019309) Folate [Moles/volume] in Red Blood Cells
282
2166
1.39
5.27
1.9
1.8
nmol/l
1073.2
1145.6
0.44
189
1678
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
261
1981
1.40
5.24
1.3
1.2
u/ml
0.9
1.5
1.49
67
540
(3024561) Albumin [Mass/volume] in Serum or Plasma
558
4747
1.31
5.22
4.8
5.4
g/l
35.4
35.0
0.85
498
4438
(3021960) Folate [Moles/volume] in Serum or Plasma
340
2697
1.35
5.18
1.6
1.6
nmol/l
20.4
19.7
0.40
271
2314
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
114
734
1.61
5.13
1.8
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
430
3536
1.32
5.12
3.9
3.3
e6/l
38.3
96.4
1.65
348
2786
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
255
1937
1.39
5.08
2.0
1.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
248
1882
1.39
4.96
1.8
2.2
s
31.0
30.2
0.77
238
1830
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
84
2.77
4.79
2.1
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
145
1007
1.49
4.67
3.0
2.7
g/l
66.1
66.4
0.15
127
936
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
497
4211
1.29
4.64
3.8
3.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
381
3121
1.31
4.58
3.1
2.9
umol/l
4064.4
7270.8
0.89
321
2713
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
106
692
1.58
4.53
1.5
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
52
278
1.91
4.51
1.4
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
350
2839
1.32
4.50
3.9
4.2
%
85.4
85.6
0.05
342
2779
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
439
3687
1.29
4.32
3.5
3.1
ug/l
0.8
0.8
0.14
296
2527
(3004588) Protein electrophoresis panel - Serum or Plasma
121
823
1.52
4.31
2.2
2.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
375
3092
1.30
4.24
3.8
3.2
—
—
—
0
0
(4146454)
31
140
2.24
4.20
2.5
2.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
306
2459
1.32
4.17
2.7
2.6
e6/l
4.0
4.1
0.06
268
2162
(3018095) Leukocytes [#/volume] in Urine
468
3991
1.27
4.02
4.6
3.8
e6/l
76.3
129.2
0.84
366
2961
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
124
2.29
3.98
1.1
1.1
u/ml
4.7
1.9
0.33
14
53
(3010726) Horse dander IgE Ab [Units/volume] in Serum
24
99
2.45
3.98
1.0
1.0
u/ml
2.6
3.8
—
5
32
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
78
490
1.63
3.93
2.0
2.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
149
1077
1.43
3.92
2.0
2.3
ug/g
151.3
161.2
0.12
110
871
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
184
1381
1.39
3.91
7.8
7.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
49
275
1.81
3.71
1.8
1.4
u/l
7.9
8.8
0.17
36
220
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
414
3510
1.26
3.66
3.1
3.4
u/l
34.1
39.4
0.39
385
3347
(3026782) Osmolality of Urine
283
2288
1.30
3.65
3.0
2.8
mosm/kgh2o
606.9
573.4
1.62
246
1951
(3021440) Promyelocytes/100 leukocytes in Blood
121
855
1.46
3.61
4.2
4.4
%
0.2
0.1
0.18
38
268
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
72
454
1.62
3.60
1.9
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
404
3423
1.26
3.58
5.0
4.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
73
464
1.61
3.54
2.4
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
435
3722
1.25
3.54
3.5
3.2
mmol/l
8.2
8.1
0.07
348
3113
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
6
10.04
3.50
1.8
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
492
4286
1.24
3.37
2.9
2.8
ug/l
164.8
164.6
0.00
442
3946
(3007164) IgA [Mass/volume] in Serum or Plasma
228
1815
1.31
3.29
1.6
1.4
g/l
2.5
2.7
0.87
133
1129
(4035726)
130
949
1.41
3.27
1.3
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
536
4725
1.23
3.25
12.4
10.0
e9/l
0.0
0.0
0.18
445
3880
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
58
356
1.66
3.24
2.1
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
416
3570
1.24
3.24
3.6
3.3
mg/l
304.7
234.5
0.15
271
2423
(3017181) Myelocytes/100 leukocytes in Blood
125
911
1.41
3.17
4.3
4.3
%
1.1
1.0
0.21
39
293
(40768797) Stomach Pathology biopsy report
190
1482
1.33
3.16
1.3
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
112
802
1.43
3.14
4.1
4.3
%
0.1
0.1
0.16
29
225
(3002179) Metamyelocytes/100 leukocytes in Blood
114
824
1.42
3.04
4.0
4.1
%
0.6
0.6
0.05
29
208
(3017732) Neutrophils [#/volume] in Blood
100
706
1.45
3.03
2.7
3.2
e9/l
3.7
4.1
1.10
63
554
(3020682) Albumin/Creatinine [Ratio] in Urine
435
3780
1.23
2.97
4.4
4.0
mg/mmol
8.6
9.5
0.20
282
2523
(3049717) Cytology report of Urine Cyto stain
87
602
1.48
2.92
2.7
2.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
36
199
1.83
2.91
1.4
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
232
1884
1.28
2.87
3.8
3.1
e6/l
1.5
1.2
0.24
144
1104
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
427
1.55
2.80
1.9
2.7
g/l
3.1
3.1
0.07
50
347
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
336
2867
1.23
2.70
2.3
2.2
mg/l
2.9
3.0
0.38
270
2459
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
10
6.02
2.70
1.0
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
141
1081
1.34
2.65
3.7
2.6
e9/l
67.6
69.8
0.37
102
839
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
60
397
1.54
2.52
2.1
2.8
g/l
1.1
1.3
0.15
50
353
(3006442) Creatine [Moles/volume] in Serum or Plasma
17
75
2.28
2.51
1.6
1.5
—
74.7
—
0
6
(3009466) Valproate [Moles/volume] in Serum or Plasma
28
152
1.86
2.44
6.2
5.0
umol/l
357.3
356.4
0.01
23
135
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
241
2005
1.25
2.43
3.2
3.2
mmol/l
2.4
2.4
0.15
208
1765
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
70
2.30
2.41
1.6
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
175
1.79
2.39
1.4
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
195
1586
1.27
2.39
1.3
1.3
iu/ml
36.7
39.5
0.09
66
479
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
141
1100
1.32
2.37
2.3
2.3
g/l
0.2
0.2
0.39
129
1023
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
131
1013
1.33
2.35
2.4
2.5
u/l
29.6
85.3
0.63
112
874
(36660697) Celiac disease serology panel - Serum
94
690
1.39
2.35
1.2
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
27
147
1.85
2.34
2.0
2.2
mg/l
14.8
19.8
—
6
33
(3027945) Reticulocytes/100 erythrocytes in Blood
178
1436
1.28
2.33
2.9
2.5
%
1.7
1.8
0.32
151
1284
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
55
365
1.53
2.31
1.5
2.6
g/l
37.2
37.5
0.12
48
323
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
47
302
1.58
2.27
1.2
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
157
1251
1.29
2.27
2.6
2.9
umol/l
6.6
10.0
3.08
132
1122
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
186
1516
1.26
2.24
1.3
1.2
u/ml
12.4
12.4
0.00
62
579
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
217
1.68
2.24
1.3
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
142
1119
1.30
2.23
2.3
2.5
ug/l
7.6
7.6
0.02
110
1020
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
29
3.12
2.22
1.4
1.1
—
—
—
0
0
(4024509)
20
100
2.02
2.21
2.1
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
66
460
1.46
2.20
1.9
2.6
g/l
3.9
3.9
0.03
50
342
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
66
460
1.46
2.20
1.9
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
66
460
1.46
2.20
1.9
2.6
g/l
7.2
7.3
0.06
50
353
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
266
2261
1.22
2.19
4.2
4.0
ng/l
251.9
812.9
0.77
220
1876
(3022689) Creatine [Moles/volume] in Urine
8
25
3.21
2.09
1.4
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
24
131
1.85
2.09
1.5
1.6
%
52.3
63.7
0.71
15
89
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
49
326
1.52
2.06
1.5
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
165
1341
1.26
2.05
1.9
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
69
2.19
2.05
1.6
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
152
1224
1.27
2.04
4.4
3.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
220
1848
1.23
2.04
2.7
2.7
umol/l
12.5
12.9
0.39
198
1717
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
44
2.51
2.01
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
163
1326
1.26
2.01
1.9
1.8
%
1.6
1.6
0.02
129
1138
(3036481) Cortisol [Moles/volume] in Serum or Plasma
119
931
1.31
1.99
2.4
2.2
nmol/l
346.1
367.7
0.60
111
862
(3004451) EKG impression Narrative
15
70
2.16
1.98
1.5
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
58
404
1.46
1.97
1.6
1.8
nmol/l
42.2
39.9
0.29
53
389
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
195
1.66
1.94
1.3
1.5
—
—
—
0
0
(4010399)
102
788
1.32
1.88
1.5
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
228
1939
1.21
1.87
3.5
3.5
mmol/l
0.8
0.8
0.17
209
1832
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
29
174
1.68
1.87
1.3
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
84
631
1.35
1.87
2.3
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
20
107
1.88
1.86
1.2
1.4
nmol/l
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
30
183
1.65
1.83
1.3
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
61
436
1.42
1.82
3.1
3.3
g/l
0.3
0.2
0.09
26
196
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
235
2010
1.21
1.82
3.5
2.9
e6/l
0.7
0.9
1.36
148
1222
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
199
1.62
1.81
4.5
3.0
e9/l
3.3
4.5
4.27
32
199
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
101
784
1.31
1.81
3.8
4.4
ng/l
88.1
101.2
0.92
85
698
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
17
87
1.97
1.80
1.6
1.4
u/l
18.3
24.2
0.22
11
69
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
21
116
1.82
1.79
1.2
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
203
1715
1.22
1.79
2.7
2.7
g/l
2.3
2.3
0.31
182
1597
(3039443) Prostate specific Ag panel - Serum or Plasma
47
321
1.48
1.78
1.5
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
194
1632
1.22
1.78
2.8
2.7
%
21.6
23.1
0.86
167
1385
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
33
208
1.60
1.78
4.5
3.3
%
54.6
58.2
0.93
33
208
(3018418) pH of Serum or Plasma
362
3223
1.17
1.77
4.6
4.3
ph
7.4
7.4
0.34
75
624
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
88
1.94
1.75
1.1
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
163
1350
1.24
1.74
1.9
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
556
5118
1.15
1.73
4.2
4.5
%
22.0
21.5
0.26
274
2587
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
35
226
1.56
1.72
1.0
1.2
—
544.0
—
0
5
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
82
1.96
1.70
1.6
1.6
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
12
55
2.19
1.67
1.1
1.1
u/l
174.4
82.0
0.51
12
40
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
136
1.70
1.59
1.5
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
73
552
1.34
1.59
1.2
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
27
167
1.63
1.59
1.6
1.5
e6/l
2358.0
1609.2
0.74
22
116
(3014051) Protein [Presence] in Urine by Test strip
36
239
1.52
1.58
3.3
2.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
26
2.70
1.58
1.4
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
21
122
1.73
1.55
1.9
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
115
930
1.26
1.53
5.5
3.7
—
—
—
0
0
(44806420)
10
44
2.28
1.53
2.4
2.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
56
409
1.39
1.52
1.1
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
257
0.54
1.51
3.2
3.7
mg/l
40.8
28.8
—
8
163
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
21
123
1.72
1.51
1.3
1.4
nmol/l
0.6
0.7
0.32
21
115
(40760892) CBC W Ordered Manual Differential panel - Blood
259
2273
1.17
1.51
5.1
4.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
21
2.87
1.50
1.0
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
16
86
1.87
1.50
1.0
1.0
u/ml
2.8
2.4
—
7
38
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
64
479
1.35
1.50
2.7
3.5
pmol/l
4.4
4.5
0.15
56
425
(4034850)
48
342
1.42
1.50
11.7
10.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
76
584
1.32
1.50
3.4
4.1
mmol/l
24.2
24.1
0.08
67
527
(46235355) HIV 1 and 2 tests - Meaningful Use set
170
1439
1.21
1.49
1.9
1.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
134
1107
1.23
1.49
4.9
7.7
mmol/l
1.4
1.4
0.08
125
1070
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
155
1301
1.22
1.48
1.4
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
128
1053
1.24
1.48
6.1
9.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
18
102
1.78
1.45
1.2
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
40
278
1.45
1.44
1.4
1.6
e6/l
14414.6
19008.1
0.32
29
206
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
72
553
1.32
1.44
2.5
1.9
ug/l
2.1
2.8
0.32
63
502
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
22
2.73
1.43
1.7
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
82
643
1.29
1.41
1.2
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
40
2.26
1.40
1.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
43
305
1.42
1.39
1.4
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
23
142
1.63
1.39
1.7
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
60
2.01
1.38
1.5
1.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
145
1220
1.21
1.36
3.7
4.4
ug/l
17.4
27.8
0.31
113
1027
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
90
1.79
1.33
1.4
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
40
283
1.43
1.33
4.0
3.9
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
29
192
1.52
1.32
3.8
4.2
%
1.1
1.3
0.09
20
155
(3012501) Base excess in Blood by calculation
39
276
1.43
1.30
5.8
5.0
mmol/l
2.9
2.4
0.37
26
187
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
83
661
1.27
1.29
5.4
10.8
mmol/l
24.2
24.3
0.17
77
628
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
132
0.45
1.28
2.3
2.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
21
130
1.63
1.27
2.2
2.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
318
2871
1.14
1.27
1.7
1.6
mmol/l
1.4
1.4
0.04
269
2371
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
26
170
1.54
1.26
4.2
3.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
23
146
1.59
1.26
1.7
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
433
1.33
1.25
1.9
2.6
g/l
10.7
10.6
0.03
49
376
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
108
891
1.23
1.24
4.8
3.9
mmol/l
1.2
1.2
1.15
94
790
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
100
1.71
1.23
1.5
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
72
568
1.28
1.21
2.9
2.4
—
—
—
0
0
(3044889) 12 lead EKG panel
813
7778
1.12
1.21
4.2
4.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
152
1302
1.19
1.20
1.4
1.3
titre
465.0
457.4
0.01
24
281
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
86
696
1.25
1.19
2.4
1.8
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
26
2.31
1.18
1.5
1.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
21
133
1.59
1.17
1.6
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
21
133
1.59
1.17
1.0
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
33
232
1.43
1.16
1.0
1.1
u/ml
4.7
10.3
—
5
19
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
59
458
1.30
1.14
2.9
2.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
111
0.45
1.13
1.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
40
2.01
1.12
1.1
2.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
22
143
1.55
1.12
1.2
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
20
127
1.58
1.11
4.8
4.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
69
549
1.27
1.11
1.5
1.3
u/ml
430.8
262.0
0.26
63
509
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
21
2.39
1.09
1.8
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
144
1.54
1.09
1.2
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
22
144
1.54
1.09
1.2
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
204
2294
0.87
1.08
4.4
3.9
kg/l
1.0
1.0
0.45
23
321
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
59
1.87
1.07
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
59
1.87
1.07
1.1
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
161
1.50
1.07
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
38
279
1.37
1.06
1.6
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
29
203
1.44
1.06
2.4
2.1
mmol/l
1.4
1.7
2.22
29
197
(3005570) Glucose [Moles/volume] in Urine
17
106
1.61
1.03
2.0
2.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
13
75
1.74
1.03
1.3
1.5
u/ml
18.2
20.8
—
5
15
(3009261) Glucose [Presence] in Urine by Test strip
551
5195
1.11
1.02
4.1
3.6
estimate
0.0
0.0
0.50
120
942
(3019832) Treponema pallidum Ab [Presence] in Serum
68
547
1.26
1.02
1.7
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
17
107
1.60
1.00
1.5
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
18
115
1.57
0.99
2.2
2.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
34
249
1.38
0.98
1.7
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
40
301
1.34
0.98
1.1
1.2
titre
55.0
87.1
—
6
24
(3019897) Erythrocyte distribution width [Ratio] by Automated count
15
92
1.64
0.97
4.3
3.1
%
13.2
13.2
0.01
15
92
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
408
1.29
0.96
3.2
3.4
mg/l
54.2
73.7
0.54
40
333
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
52
408
1.29
0.96
3.3
3.4
mg/l
35.0
82.9
0.85
40
334
(3016879) Cocaine [Presence] in Urine
31
225
1.39
0.95
1.8
2.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
59
472
1.26
0.94
1.2
1.9
u/l
37.6
38.7
0.19
52
413
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
25
175
1.44
0.93
1.3
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
19
126
1.52
0.91
1.2
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
72
592
1.23
0.91
1.7
1.9
g/l
1.5
1.5
0.01
61
513
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
109
934
1.18
0.90
2.9
2.9
ml/min/173m2
63.3
64.0
0.09
51
376
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
63
1.75
0.90
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
62
502
1.25
0.90
1.2
1.2
iu/ml
96.3
148.6
1.25
20
190
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
10
56
1.79
0.88
2.1
1.4
u/field
1.7
2.2
—
10
39
(3026008) Bacteria identified in Urine by Culture
316
2918
1.11
0.87
3.5
3.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
6
30
2.00
0.87
4.7
2.1
nmol/l
131.8
132.5
—
6
24
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
64
1.72
0.86
1.4
2.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
22
153
1.45
0.86
1.6
1.5
e6/l
114510.2
84552.0
0.13
14
90
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
38
291
1.32
0.85
1.6
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
72
1.67
0.85
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
72
1.67
0.85
1.1
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
13
80
1.63
0.84
1.5
2.0
—
42.4
—
0
10
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
31
1.94
0.84
1.3
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
542
5145
1.09
0.84
4.2
3.5
estimate
0.0
0.0
0.00
122
978
(3017143) Hepatitis C virus Ab [Presence] in Serum
122
1063
1.16
0.84
1.7
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
540
5126
1.09
0.83
5.3
4.7
estimate
0.0
0.0
0.00
123
998
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
122
1064
1.16
0.83
3.3
2.9
ng/l
307.8
222.4
0.55
112
965
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
33
249
1.33
0.82
4.3
5.8
iu/ml
2063.7
957.7
—
6
40
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
163
1.42
0.82
1.1
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
32
1.88
0.82
1.3
1.1
—
—
—
0
0
(4198724)
6
32
1.88
0.82
1.5
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
16
105
1.53
0.82
1.2
1.2
u/l
65.8
57.4
—
9
72
(3000764) Benzodiazepines [Presence] in Urine
32
241
1.34
0.81
1.8
2.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
891
8652
1.09
0.80
21.7
19.3
%
13.8
13.8
0.10
874
8458
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
23
164
1.41
0.80
1.3
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
67
556
1.22
0.80
3.8
3.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
29
216
1.35
0.79
1.5
1.8
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
6
33
1.82
0.79
1.0
1.2
%
102.7
108.5
—
6
27
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
33
1.82
0.79
1.2
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
33
1.82
0.79
2.2
2.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
149
0.60
0.79
1.2
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
66
1.67
0.78
1.3
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
66
1.67
0.78
1.3
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
66
1.67
0.78
1.3
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
66
1.67
0.78
1.3
2.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
18
123
1.47
0.77
4.7
4.4
%
61.5
55.8
0.42
11
83
(3022621) pH of Urine by Test strip
81
687
1.19
0.77
3.1
2.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
32
243
1.32
0.77
1.7
2.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
32
244
1.32
0.76
1.8
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
14
91
1.54
0.75
1.1
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
12
75
1.61
0.75
1.6
3.0
—
35.9
—
0
26
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
175
1.38
0.75
1.5
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
141
1.42
0.74
1.1
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
39
307
1.28
0.74
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
133
1.43
0.73
2.9
5.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
34
263
1.30
0.73
3.3
2.7
%
15.4
16.1
0.37
19
134
(4015189)
7
38
1.85
0.73
1.4
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
9
55
1.64
0.73
3.2
1.7
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
55
1.64
0.73
2.6
1.3
ug/l
8.2
8.9
—
9
47
(3051593) INR in Capillary blood by Coagulation assay
9
55
1.64
0.73
5.8
18.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
228
1.32
0.73
1.7
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
25
2.00
0.72
1.4
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
142
1.41
0.72
1.1
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
142
1.41
0.72
1.1
1.5
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
11
68
1.62
0.71
1.4
1.4
nmol/l
1.0
1.1
—
6
51
(3033799) Differential panel - Peritoneal fluid
7
40
1.75
0.71
1.6
2.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
143
1.40
0.70
1.1
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
101
1.49
0.70
1.7
1.4
%
18.4
26.4
—
10
68
(3020876) Protein [Mass/time] in 24 hour Urine
15
101
1.49
0.70
2.4
2.0
—
1.6
—
0
6
(3047181) Lactate [Moles/volume] in Blood
31
398
0.77
0.70
7.7
7.9
mmol/l
1.2
1.4
0.43
26
344
(3000570) Elastase.pancreatic [Mass/mass] in Stool
38
301
1.27
0.70
1.3
1.5
ug/g
347.7
274.4
1.79
25
184
(3002523) Influenza virus A Ag [Presence] in Specimen
9
142
0.63
0.70
1.4
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
39
310
1.27
0.70
1.2
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
39
310
1.27
0.70
3.4
3.0
mg/l
1.7
1.6
0.21
33
282
(3021447) Carbon dioxide [Partial pressure] in Venous blood
135
1204
1.14
0.69
4.6
3.9
kpa
5.9
5.8
0.27
128
1166
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
11
69
1.60
0.68
1.5
1.6
u/l
2.8
6.5
—
5
37
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
222
1.31
0.68
2.1
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
39
311
1.26
0.68
1.4
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
20
144
1.39
0.68
1.5
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
31
240
1.30
0.68
1.7
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
49
402
1.23
0.67
1.1
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
95
829
1.16
0.67
2.5
2.7
g/l
10.5
10.7
0.11
82
766
(3042631) Mycobacterium sp identified in Specimen
24
179
1.35
0.67
2.5
2.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
93
0.54
0.67
1.2
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
43
1.63
0.67
1.6
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
94
1.49
0.67
1.4
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
70
1.58
0.65
1.1
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
134
1202
1.13
0.64
4.5
3.9
mmol/l
1.6
2.0
0.58
111
944
(3008152) Bicarbonate [Moles/volume] in Arterial blood
71
825
0.85
0.63
7.9
7.9
mmol/l
25.4
24.4
1.31
66
770
(3044941) Cell count panel - Synovial fluid
24
181
1.33
0.63
1.5
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
38
306
1.25
0.63
1.2
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
17
121
1.41
0.62
1.2
1.3
pmol/l
267.6
294.9
0.18
17
96
(3028026) IgM [Mass/volume] in Serum or Plasma
77
666
1.17
0.62
2.3
1.8
g/l
1.9
1.5
0.26
66
615
(3034891) Synovial lining cells/100 cells in Synovial fluid
8
49
1.64
0.62
1.8
1.4
—
1.3
—
0
11
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
28
217
1.30
0.62
1.9
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
304
2851
1.09
0.62
4.8
3.9
estimate
0.0
0.0
0.39
116
934
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
191
1.31
0.61
1.8
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
26
200
1.31
0.61
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
296
2775
1.09
0.61
3.9
3.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
51
1.57
0.60
1.1
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
141
0.64
0.60
1.4
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
21
0.00
0.60
0.0
10.8
—
6.0
—
0
21
(3017569) Oxygen content in Arterial blood
11
72
1.53
0.59
2.7
2.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
114
1.41
0.59
1.3
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
114
1.41
0.59
1.3
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
114
1.41
0.59
1.3
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
307
2887
1.08
0.59
1.4
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
36
291
1.24
0.58
1.4
2.0
mg/l
18.0
11.3
0.49
31
265
(3021879) Hepatitis B virus core Ab [Presence] in Serum
76
662
1.16
0.57
1.4
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
247
1.26
0.57
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
247
1.26
0.57
1.4
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
36
1.67
0.56
1.8
1.0
miu/ml
1722.8
1403.0
—
6
36
(3042733) HLA Ab [Presence] in Serum
6
36
1.67
0.56
5.5
5.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
14
98
1.43
0.56
1.2
2.1
e9/l
1.0
1.0
—
8
52
(40761535) Cells panel - Urine sediment
110
985
1.13
0.56
3.3
3.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
124
1.38
0.56
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
221
1.27
0.55
1.7
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
18
239
0.75
0.54
1.5
1.2
mmol/l
3.8
3.9
0.24
18
223
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
82
1.47
0.54
1.2
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
38
1.58
0.54
1.2
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
169
1.31
0.53
2.0
2.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
110
989
1.12
0.53
4.1
3.1
kpa
4.4
4.5
0.39
104
954
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
134
1.35
0.53
1.3
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
62
1.45
0.53
1.7
1.2
nmol/l
128.2
145.7
—
9
62
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
66
1.52
0.52
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
258
2423
1.08
0.52
1.9
1.7
pmol/l
427.9
23619748.7
1.69
188
2028
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
64
1.41
0.51
1.8
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
109
1.38
0.51
1.3
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
14
191
0.73
0.51
1.7
1.3
mmol/l
56.6
64.8
—
8
165
(3048929) Epstein Barr virus Ab [Presence] in Serum
37
306
1.22
0.51
1.4
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
53
454
1.17
0.50
1.3
1.3
—
—
—
0
0
(3000492) Spirometry study
112
1012
1.12
0.50
1.5
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
65
1.39
0.50
1.1
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
65
1.39
0.50
1.1
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
92
1.42
0.50
1.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
279
1.22
0.50
1.9
1.8
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
41
1.47
0.50
1.7
1.3
ug/l
2.2
3.2
—
6
31
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
25
198
1.27
0.49
1.8
1.5
u/ml
121.2
132.4
—
5
32
(3013139) Helicobacter pylori Ag [Presence] in Stool
73
643
1.14
0.49
1.3
1.3
—
—
—
0
0
(3015736) pH of Urine
418
4004
1.06
0.48
3.5
3.3
—
5.8
—
0
5
(3011288) Drugs identified in Urine by Screen method
21
163
1.29
0.48
2.5
2.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
18
137
1.32
0.47
1.1
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
10
68
1.47
0.47
1.2
1.4
—
52.5
—
0
8
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
48
1.46
0.47
1.6
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
48
1.46
0.47
1.4
2.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
48
1.46
0.47
1.4
2.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
209
1.25
0.46
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
120
1.34
0.46
1.4
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
49
1.43
0.46
5.6
7.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
81
0.62
0.46
2.4
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
121
0.66
0.45
1.0
1.1
—
—
—
0
0
(4211845)
7
50
1.40
0.45
2.9
2.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
50
1.40
0.45
1.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
69
1.45
0.44
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
69
1.45
0.44
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
69
1.45
0.44
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
119
1089
1.10
0.44
1.6
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
78
1.41
0.43
1.9
1.5
g/l
0.9
1.0
0.31
11
78
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
158
1468
1.09
0.43
5.7
8.3
kpa
5.1
5.1
0.28
147
1402
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
113
1.33
0.42
2.5
2.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
273
0.80
0.42
4.7
2.8
u/ml
70.4
56.1
0.20
22
264
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
56
1.43
0.42
1.1
2.5
u/ml
1222.9
1269.1
—
8
56
(3027801) Oxygen [Partial pressure] in Arterial blood
158
1469
1.09
0.42
5.7
8.3
kpa
12.4
12.0
0.37
147
1405
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
184
0.76
0.42
1.2
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
30
249
1.21
0.42
1.2
1.6
nmol/l
0.8
0.8
0.22
24
209
(21494814) CD8 cells/100 lymphocytes in Specimen
5
33
1.52
0.41
1.4
2.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.9
—
69.9
—
0
15
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.8
—
2.2
—
0
8
(3044290) Cell count panel - Cerebral spinal fluid
26
213
1.23
0.41
1.7
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
59
1.36
0.41
2.5
3.7
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
5
34
1.47
0.40
1.0
1.1
—
0.4
—
0
6
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
88
1.37
0.40
1.1
1.2
titre
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
23
187
1.23
0.39
2.6
2.9
u/ml
—
2344.4
—
0
18
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
40
345
1.16
0.38
1.2
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
68
1.33
0.37
5.2
3.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
68
1.33
0.37
2.8
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
268
0.82
0.37
1.3
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
126
1168
1.09
0.37
7.6
7.9
mmol/l
10.9
10.5
0.28
112
1110
(1002224) Polysomnography panel
46
402
1.15
0.37
1.1
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
8
112
0.71
0.37
1.1
1.4
pmol/l
139.5
227.8
—
8
112
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
5
37
1.35
0.37
1.2
2.1
ug/l
19.5
242.5
—
5
31
(3004616) Nuclear Ab [Presence] in Serum
17
134
1.27
0.37
1.4
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
207
1.21
0.36
1.6
1.2
u/ml
241.7
280.9
0.29
17
119
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
235
1.20
0.36
1.2
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
108
1.30
0.35
1.4
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
108
1.30
0.35
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
16
126
1.27
0.35
1.3
1.3
mu/l
34.2
50.6
0.37
16
116
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
218
1.20
0.34
1.5
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
82
1.34
0.34
1.0
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
91
1.32
0.33
1.4
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
45
1.33
0.33
1.2
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
45
1.33
0.33
3.0
2.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
46
1.31
0.33
1.7
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
6
47
1.28
0.32
1.0
1.1
—
7.4
—
0
11
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
146
1.24
0.32
1.2
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
29
248
1.17
0.32
1.2
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
316
0.85
0.32
1.7
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
97
0.72
0.31
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
138
1.23
0.30
2.1
2.2
u/l
3161.3
3853.9
—
8
51
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
37
326
1.14
0.29
1.1
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
20
238
0.84
0.29
1.8
1.4
e6/l
289.1
216.4
0.10
14
201
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
20
238
0.84
0.29
1.8
1.3
e6/l
8.2
40.7
0.70
13
193
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
111
0.72
0.28
1.3
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
11
140
0.78
0.28
1.1
1.1
%
115.8
113.5
0.14
11
128
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
10
76
1.32
0.28
1.3
2.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
35
308
1.14
0.28
1.2
1.2
—
1406.3
—
0
8
(3003338) MCHC [Mass/volume]
868
8797
0.96
0.28
22.6
20.7
g/l
333.4
333.2
0.22
863
8732
(3037756) Immunofixation for Serum or Plasma
30
261
1.15
0.28
2.5
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
89
828
1.08
0.27
1.6
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
30
262
1.15
0.26
2.4
3.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
155
1472
1.06
0.26
5.7
8.3
mmol/l
0.9
1.1
0.42
123
1137
(3050129) First trimester maternal screen panel - Serum or Plasma
13
104
1.25
0.26
1.5
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
8
67
1.20
0.26
1.3
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
26
225
1.16
0.26
1.7
1.4
—
15.2
—
0
6
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
74
0.67
0.26
1.2
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
75
1.20
0.25
2.7
2.5
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
11
87
1.27
0.24
1.0
1.1
—
63.8
—
0
8
(3027456) Digoxin [Moles/volume] in Serum or Plasma
29
255
1.14
0.24
2.7
3.0
nmol/l
0.8
0.9
0.65
23
191
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
17
201
0.84
0.24
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
409
3990
1.04
0.23
4.3
3.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
38
1.32
0.23
1.0
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
12
97
1.24
0.23
1.8
1.3
g/l
4.9
7.7
—
7
66
(3024139) IgG subclass 3 [Mass/volume] in Serum
12
97
1.24
0.23
1.8
1.3
g/l
0.3
0.5
—
7
66
(3020961) Endomysium IgA Ab [Titer] in Serum
37
410
0.90
0.22
1.1
1.1
—
97.3
—
0
7
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
125
1188
1.06
0.22
1.7
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
36
324
1.11
0.22
4.4
3.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
107
1.22
0.21
1.6
1.7
—
—
—
0
0
(4212803)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
115.3
—
0
10
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
38
344
1.11
0.21
1.5
2.3
%
83.0
88.2
0.72
38
329
(4062490)
12
98
1.23
0.21
1.8
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.9
—
8.0
—
0
6
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
49
532
0.92
0.20
6.4
6.4
%
1.6
1.6
0.10
44
497
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
111
0.81
0.20
2.2
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
20
174
1.15
0.19
1.1
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
12
99
1.21
0.19
1.4
1.5
pmol/l
38.1
398.0
—
6
28
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
51
1.18
0.19
1.7
3.6
u/ml
15.6
74.8
—
6
51
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
51
1.18
0.19
1.2
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
27
241
1.12
0.19
3.0
3.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
53
1.13
0.18
1.3
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
53
1.13
0.18
2.3
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
68
724
0.94
0.18
1.6
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
118
1234
0.95
0.18
6.8
9.0
g/l
121.5
122.0
0.11
112
1188
(3044927) Protein electrophoresis panel - Urine
17
147
1.16
0.18
1.1
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
164
1584
1.04
0.17
6.6
6.6
mmol/l
1.1
1.0
1.33
149
1487
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
70
0.71
0.16
1.0
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
70
0.71
0.16
1.0
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
68
1.18
0.16
4.5
4.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
244
1.11
0.16
1.1
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
73
1.10
0.15
1.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
15
130
1.16
0.15
1.4
2.0
—
1616.0
—
0
5
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
75
788
0.95
0.14
1.6
1.8
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
86
0.81
0.14
1.3
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
86
0.81
0.14
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
86
0.81
0.14
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
86
0.81
0.14
1.3
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
93
1.18
0.14
1.5
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
27
246
1.10
0.14
1.2
1.2
u/ml
17.3
5.8
—
5
37
(21494755) Public health laboratory ask at order entry panel
75
785
0.95
0.13
1.4
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
138
0.87
0.13
2.6
2.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
33
306
1.08
0.13
4.1
3.5
—
—
—
0
0
(4306422)
13
148
0.88
0.12
1.2
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
84
875
0.96
0.12
4.9
5.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
37
346
1.07
0.12
1.2
1.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
50
528
0.94
0.12
6.4
6.4
%
0.8
0.9
0.28
45
494
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
24
222
1.08
0.10
3.0
1.2
u/l
38.8
48.9
0.17
19
192
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
44
1.14
0.10
1.0
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
46
1.09
0.09
3.6
2.7
—
—
—
0
0
(3017704) Immunofixation for Urine
10
87
1.15
0.09
2.5
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
13
116
1.12
0.09
1.0
1.0
u/ml
1.9
2.3
—
6
43
(3037556) Urate [Mass/volume] in Serum or Plasma
5
48
1.04
0.09
1.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
247
2431
1.02
0.09
4.0
3.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
56
1.07
0.08
1.2
1.2
iu/ml
86.5
221.9
—
6
56
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
57
1.05
0.08
21.8
18.8
nmol/l
843.0
1403.7
—
6
57
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
479
1.05
0.08
2.5
2.8
u/ml
0.4
0.3
0.86
31
274
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
50
521
0.96
0.08
1.3
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
27
287
0.94
0.08
1.2
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
66
1.06
0.08
1.1
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
66
1.06
0.08
1.1
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
133
0.90
0.07
1.5
1.9
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
313
1.06
0.07
1.8
1.6
iu/ml
0.2
21.2
—
8
57
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
8
78
1.03
0.07
1.9
1.2
mmol/l
1.8
2.0
—
8
73
(3020891) Body temperature
54
523
1.03
0.06
6.0
4.6
—
—
—
0
0
(4094501)
32
306
1.05
0.05
1.1
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
32
308
1.04
0.04
1.5
2.4
%
191.8
197.2
0.12
32
293
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
32
332
0.96
0.04
2.0
2.4
ug/min
55.3
109.8
0.81
15
203
(3024980) IgG subclass 4 [Mass/volume] in Serum
17
160
1.06
0.04
1.5
1.7
g/l
0.7
0.9
0.50
11
123
(4268621)
11
101
1.09
0.04
2.2
2.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
31
299
1.04
0.03
4.0
4.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
149
0.94
0.03
1.1
1.2
u/ml
1.4
5.0
—
5
53
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
149
0.94
0.03
1.1
1.2
u/ml
5.1
6.3
—
7
68
(3016502) Oxygen saturation in Arterial blood
135
1337
1.01
0.02
6.2
8.7
%
95.3
95.5
0.11
125
1289
(44806118)
15
142
1.06
0.02
1.4
1.5
—
—
—
0
0
(44790047)
15
142
1.06
0.02
1.4
1.5
—
—
—
0
0
(44790049)
15
142
1.06
0.02
1.4
1.5
—
—
—
0
0
(44790048)
15
142
1.06
0.02
1.4
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
68
689
0.99
0.01
8.7
12.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
10
106
0.94
0.01
1.1
1.1
%
100.8
95.2
—
10
99
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
164
1.04
0.00
2.8
2.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
363
3624
1.00
0.00
3.1
3.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
104
0.96
0.00
1.8
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
30
296
1.01
0.00
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
98
1.02
0.00
3.2
2.1
%
12.0
11.3
—
10
98
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
10
102
0.98
0.00
1.3
1.2
nmol/l
1.1
1.5
—
10
93
(3051611) Lipemic interference index of Serum or Plasma
10
102
0.98
0.00
4.9
4.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
121
0.99
0.00
1.4
1.9
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
27
269
1.00
0.00
4.9
3.5
mmol/l
7.2
7.6
0.44
27
264
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
163
0.98
0.00
1.3
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
35
347
1.01
0.00
1.1
1.1
—
2.2
—
0
5
(3006184) Hemoglobin [Mass/volume] in Capillary blood
26
265
0.98
0.00
2.8
2.3
g/l
122.9
129.2
0.61
21
197
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
35
355
0.99
0.00
1.3
1.7
mg/l
3.4
3.0
0.10
23
257
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
105
0.95
0.00
1.3
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
145
0.97
0.00
1.0
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
7
69
1.01
0.00
1.1
1.0
mg/l
196.4
298.5
—
7
60
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
1709.6
—
0
5
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
64.8
—
0
5
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
5
0.00
0.00
0.0
1.8
—
289.4
—
0
5
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.0
—
382.8
—
0
6
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
1.0
1.2
—
—
—
0
0
(4281824)
7
79
0.89
0.00
1.4
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
68
0.88
0.00
2.8
1.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
49
1.02
0.00
1.0
1.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
8
0.00
0.00
0.0
2.1
—
1.6
—
0
8
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
24.2
—
0
8
(44813793)
5
58
0.86
0.00
1.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
57
0.88
0.00
1.0
1.5
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.0
—
17.4
—
0
6
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
72
0.97
0.00
1.6
1.5
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
65
0.92
0.00
1.2
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3001729) Color of Synovial fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
57
0.88
0.00
1.0
1.5
—
—
—
0
0
(4027681)
5
53
0.94
0.00
1.8
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
5.4
—
0
7
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
0
9
0.00
0.00
0.0
1.0
—
8.6
—
0
9
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H8_EXTDISNAS and mortality.

Females

Parameter HR [95% CI] p-value
H8_EXTDISNAS 1.237 [1.0, 1.53] 0.05
Birth year 0.992 [0.98, 1.0] 0.063

During the follow-up period (1.1.1998 — 31.12.2019), 211 out of 1882 females with H8_EXTDISNAS died.

Males

Parameter HR [95% CI] p-value
H8_EXTDISNAS 0.863 [0.76, 0.98] 0.02
Birth year 0.988 [0.98, 1.0] 0.016

During the follow-up period (1.1.1998 — 31.12.2019), 652 out of 4632 males with H8_EXTDISNAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_EXTDISNAS.

N-year risk Females Males
1 0.1% 0.141%
5 0.707% 1.015%
10 1.709% 2.44%
15 3.23% 4.766%
20 5.448% 8.588%

Relationships between endpoints

↥

Index endpoint: H8_EXTDISNAS – Other specified disorders of external ear

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data